SCHEMBL10201501

SCHEMBL10201501

C#Cc1ccc2[nH]c([C@@H]3C[C@H]4CC4N3C(=O)OC(C)(C)C)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 7/20 0.39
GABRB3 P28472 7/20 0.39
GABRA1 P14867 6/20 0.39
GABRA2 P47869 6/20 0.39
GABRA5 P31644 5/20 0.39
GABRA6 Q16445 5/20 0.39
GABRA3 P34903 5/20 0.39
GABRA4 P48169 2/20 0.39
GABRB2 P47870 1/20 0.33
HCRTR1 O43613 3/20 0.32
HCRTR2 O43614 3/20 0.32
AR P10275 1/20 0.31
GPR119 Q8TDV5 2/20 0.31
JAK1 P23458 1/20 0.31
PARP1 P09874 1/20 0.30
PTGES O14684 2/20 0.30
KAT2B Q92831 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12373582 1.00 GABRG2 (0.39) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL12798776 0.91 GABRA1 (0.39) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL19488770 0.89 GABRA1 (0.42) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL12373562 0.89 GABRA1 (0.42) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL12849501 0.87 CHEK2 (0.35) HCRTR1HCRTR2GPR119JAK1PARP1
SCHEMBL10201123 0.85 CDK1 (0.36) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL1293357 0.85 CDK1 (0.36) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL1293358 0.85 CDK1 (0.36) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL10200232 0.85 GABRG2 (0.35) GABRG2GABRB3GABRA1GABRA2GABRA5
SCHEMBL12295805 0.85 GABRG2 (0.35) GABRG2GABRB3GABRA1GABRA2GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398794-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2013-01-16 EP disclosed
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 WO disclosed